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Lāngali (Gloriosa superba L.) is a drug in upaviṣa varga (semi-poisonous drug) which has to undergo śodhana 
procedure before its therapeutic use. The present study was planned to assess the role of śodhana of Lāngali tuber by 
gomūtra on its safety aspects in experimental animals, which is recommended by Ayurvedic Formulary of India. The 
therapeutic dose of Lāngali as per API is 125 to 250 mg/day. For the present study the higher dose i.e. 250 mg was selected. 
Wistar strain albino rats were used for the study. The animals were divided into seven groups and each group contained 12 
animals (six male and six female). The study was done for 90 days followed by 30 days (total 120 days) recovery study. 
Various haematological, biochemical parameters and histopathology of the organs were studied. The study showed that 
śodhana process attenuates the toxicity producing potential of raw Lāngali. When processed with gomūtra, lāngali root 
produces good spermatogenic effect while raw/ aśodhita lāngali hampers spermatogenesis at 10 times dose level. So it can 
be concluded that both raw and śodhita Langali found relatively safe up to 5 times therapeutic dose level. 
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Introduction 
Therapeutic safety is much essential than efficacy, 
for any drug, used either to prevent or cure any 
disease. It becomes more necessary when the drug is 
known for its adverse effects. In Ayurvedic system of 
medicine, ‘śodhana’ (processing) procedures have 
been adopted to ensure both safety and therapeutic 
efficacy of certain viṣa (poisonous) drugs1. According 
to Ayurveda, viṣa (poison) when used with proper 
yukti (justification) can be good medicine, in the same 
way, a medicine, if not used in a proper way, can act 
as a viṣa (poison)2. To ensure safety and efficacy of 
the drugs, the word Yukti, can be considered as a 
selection of proper dose, duration, dosage form, after 
purification with different media etc. It is therefore 
essential to evaluate the safe margin of therapeutic 
effective poisonous drugs used in the recommended 
dose and prolonged duration.  
Ayurvedic pharmacopoeia recommends Lāngali, a 
drug among upaviṣa (less poisonous) group of drugs, 
in various disease conditions, both internally or 
externally, such as kuṣṭha (skin disease), arśa (piles), 
jwara (pyrexia), karnaroga (ear diseases), indralupta 
(alopecia) either as a single drug or part of compound 
formulations and also used as rasāyana in low doses3. 
It recommends the use of this drug, like other 
poisonous drugs, after śodhana4. Lāngali contains 
colchicine (ranging from 0.15 to 0.56%), an active 
constituent, which is reported for its toxic effects5. 
The toxicity of colchicines is dose-dependent. The 
high fatality rate was reported after acute ingestions 
exceeding 0.5 mg/kg. The lowest reported lethal  
doses of oral colchicine are 7-26 mg6. Some other 
chemical constituents are gloriosine, N-formyl 
desacetylcolchicine, monomethyl γ-resorcylate and 
colchicoside7. It is considered that, by the process of 
śodhana, harmful elements from the dravya are 
pacified and it is made compatible with the human 
body8. Ayurvedic Formulary of India recommends 
śodhana of Lāngali with gomūtra9 but in routine 
practice, it is used in raw condition only. Animal 
experimentation is the only way for the assessment of 
risk factors. A recent review of the literature shows 
that neither raw nor śodhita Lāngali has been 
evaluated for their toxic effects in an animal study10. 
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Hence, to assess the toxic effect, if any, chronic 
toxicity for 90 consecutive days of aśodhita (Raw) 
Lāngali tuber and gomūtra śodhita Lāngali was 
evaluated experimentally on therapeutic dose as well 
as five times and ten times higher than the therapeutic 
dose. Further, to observe the recovery of the 
experimental animals from toxicity after a certain 
interval of toxicity study is one of the recommendations 
of the World Health Organization (WHO) guidelines 
for conducting toxicity study5. Therefore after 
prolonged exposure to the higher dose of Lāngali, if 
the animals recovered from the toxic effect or not, 
should also be observed. Hence, the present study was 
planned to assess the role of śodhana on Lāngali root 
on its safety aspects in experimental animals.  
 
Materials and Methods 
 
Test drugs 
Gloriosa superba L. was identified as Lāngali in 
the field by observing its reported taxonomical and 
morphological characters11-14. Fresh and mature tubers 
were collected from Salem district of Tamil Nadu, 
78.14° East altitude and 11.67° North longitude, in 
the month of December 2010. A sample herbarium 
has been preserved in Pharmacognosy Laboratory of 
the Institute (Herbarium no. Phm/6060). Śodhana was 
performed in the department of Dravyaguna using 
gomūtra as media15. For the purpose of śodhana, raw 
tubers (250 g) were cut into pieces, dipped in 750 mL 
gomūtra collected from the local cowshed and 
allowed to stand for overnight. Then they were taken 
out the next morning, washed with lukewarm water 
and dried under sunlight. Dried śodhita sample was 
powdered, stored in an airtight glass container and 
labelled as GS. The raw (Aśodhita) Lāngali was also 
powdered and kept labelled as AS. 
 
Animals 
Wistar strain albino rats of either sex, weighing 
210±60 g were used for the study. The animals were 
obtained from the animal house (Registration 
No.548/2002/CPCSEA) attached to I.P.G.T.&R.A., 
Gujarat Ayurved University, Jamnagar. Six animals 
were housed in each cage. They were housed at 
22±3°C with constant humidity 50-70%, on a 12 h 
day and night cycle. They were fed with Amrut brand 
rat pellet feed supplied by Pranav Agro Industries and 
with tap water ad libitum. The experimental protocol 
was approved (dated 13/09/2011) by the Institutional 
Animals Ethics Committee (IAEC/09/11/01) as per 
OECD 452 guideline. 
Dose 
The therapeutic dose of Lāngali as per API is  
125 to 250 mg/day. For the present study, the higher 
dose i.e. 250 mg was selected. The rat dose was 
calculated by extrapolating the human dose to animal 
dose based on the body surface area ratio. The dose 
fixation was done on the basis of body surface area 
ratio using the table of Paget and Barnes (1964) as 
follows16. 
 
Human dose × body surface area ratio convertibility 
factor 
Dose for rats: Human dose×0.018 
= 250 mg×0.018 
=4.5 mg/200g body weight of rat 
=22.5 mg/kg/day of rat 
For the animal experiment, the test drugs were 
made into fine suspension with the help of carboxy 
methyl cellulose (q.s.) procured from Thomas Baker 
company as a suspending agent, in vehicle (deionized 
water) in a suitable concentration and administered by 
oral route with a gastric catheter. 
 
Study protocol for chronic toxicity (main study) 
Twelve animals were taken in each group for the 
present study and divided into seven groups. Details of 
grouping, naming and dose are presented in Table 1. 
Bodyweight was noted down before the 
commencement of the study and afterwards every 7th 
day and also before sacrifice along with general 
behaviour pattern by exposing each animal to open 
arena. On the 91st day, 6 rats from each group were 
sacrificed; blood was collected by puncturing supra-
Table 1 — Details of grouping and sex of animals in chronic 
toxicity study 
Cage  
number 
Groups Dose  
(mg/kg) 
Sex Duration  
(Days) 
1 Control -- Male 90 
2 Control -- Female 90 
3 AS TED* 22.50 Male 90 
4 AS TED* 22.50 Female 90 
5 AS TED × 05 112.50 Male 90 
6 AS TED × 05 112.50 Female 90 
7 AS TED × 10 225 Male 90 
8 AS TED × 10 225 Female 90 
9 GS TED* 22.50 Male 90 
10 GS TED* 22.50 Female 90 
11 GS TED × 05 112.50 Male 90 
12 GS TED × 05 112.50 Female 90 
13 GS TED × 10 225 Male 90 
14 GS TED × 10 225 Female 90 
*TED – Therapeutically equivalent dose; AS – Aśodhita, GS – 
Gomūtra śodhita 
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orbital plexus for haematological and biochemical tests. 
All vital organs were collected, cleaned, weighed and 
the histopathological study was carried out. 
 
Study protocol for chronic toxicity (recovery study) 
Six rats, an equal number of male and female from 
each treated groups were kept for recovery study. 
During this recovery period (30 days after the main 
study), no drug was administered, and only normal 
diet and drinking water were given during the 
recovery period. This schedule was continued for  
30 days after treatment of 90 days in the main study. 
Gross behaviour was observed throughout the period 
of study. On the 121st day, rats were sacrificed. 
 
Morphological and histopathological studies 
Various organs i.e. liver, heart, lung, spleen, brain, 
pituitary, thymus, trachea, stomach, intestine, kidney, 
testis, prostate, uterus, seminal vesicles, skin, and uterus 
were removed and dissected carefully. The organs  
were transferred to 10% formaldehyde solution for 
preservation. The sections were cut, taken on a slide and 
were stained by serially placing them in xylol, acetone, 
95% alcohol, running water, hematoxylin to stain the 
cytoplasm of the cells and eosin to stain the nuclei, and 
mounted by using diphenlypthalein xylene (DPX), a 
coverslip was placed. They were studied under the 
binocular research Carl-Zeiss microscope (Germany) at 
various magnifications to note down the changes in the 
microscopic features of the tissues studied. 
 
Statistical analysis 
All the values were expressed as mean±SEM 
(standard error of mean). Statistical analysis was done 
by applying student ‘t’ test. ANOVA followed by 
Dunnett's multiple ‘t’ test was applied where results  
of ‘t’ test were found significant and data was recorded. 
A level of P <0.05 was considered as statistically 
significant level of significance was noted and 
interpreted accordingly. 
 
Results and Discussion 
No mortality was observed during the chronic 
toxicity study. No significant behavioural changes 
were observed. Food intake was also not affected by 
the chronic administration of both raw and śodhita 
Lāngali at all the dose levels. Analysis of the results 
of the chronic toxicity study showed some similarities 
and dissimilarities between śodhita Lāngali and 
aśodhita Lāngali administered groups. 
The body weight gain pattern was comparable in 
both the sample administered groups. This indicates 
that chronic administration of either form of test drugs 
has no adverse effect on the nutrition assimilation 
status of the animals. Normal progressive body 
weight gain was observed in normal control as well as 
all treated group (Table 2). However, percentage 
increase in body weight was higher in AS (23.75%), 
AS TED 5 (31.06%), AS TED 10 (24.45%); as well 
as GS (24.21%), GS TED 5 (31.65%), GS TED 10 
(27.09%) treated group as compared to control group 
(12.52%). 
 
Effect on ponderal changes on various organs 
There are no statistically significant changes in the 
relative weight of organs like heart, liver, seminal 
vesicle, prostrate and uterus except decrease (P <0.05) 
Table 2 — Effect of AS and GS on body weight of albino rats 
Body weight (g) 
Experimental phase Recovery phase 
Groups 0 day 30th day 60th day 90th day % change 
(0 to 90 days) 
120th day % change 
(0 to 120 days) 
Control 211.00 ±14.57 
227.25 
±14.58 
228.57 
±18.95 
237.43 
±20.63 12.52↑ -- - 
AS TED 200.67 ±8.67 
205.00 
±6.19 
222.67 
±6.82 
248.33 
±17.94 23.75↑* -- - 
AS TED×05 173.27 ±6.42 
189.27 
±7.06 
208.91 
±5.03 
227.09 
±9.69 31.06↑* 
231.20 
±11.62 33.43↑* 
AS TED×10 173.27 ±7.33 
180.73 
±9.49 
182.72 
±10.08 
215.64 ± 
11.89 24.45↑* 
234.40 
±21.17 35.28↑* 
GS TED 191.33 ±12.40 
186.67 
±10.22 
206.00 
±12.29 
237.67 
±20.99 24.21↑ -- - 
GS TED×05 165.45 ±8.63 
181.09 
±8.86 
199.64 
±8.44 
217.82 
±12.17 31.65↑* 
220.40 
±15.34 33.21↑* 
GS TED×10 174.17 ±5.23 
183.67 
±4.79 
193.17 
±7.75 
221.36 
±7.34 27.09↑* 
255.67 
±19.56 46.79↑* 
Data: Mean±SEM, ↑-Increase,  - Decrease, *P <0.05 when comaperd to initial values (Paired ‘t’ test) 
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was observed in thymus weight in GSTED×10 treated 
group and uterus weight in AS TED and GS TED 
groups. A significant increase was observed in spleen 
weight in GS TED group while, thymus in AS TED10 
as well as GS TED10 treated groups (Table 3).  
It may be said that some of the active principles  
in the drug may be helpful in the increase in  
body weight of the animals. It is observed that 
aqueous, chloroform and alcohol extract of  
G. superba resulted in an increase in body weight  
and organ weight at the dose of 500 mg/kg body 
weight in a dose-dependent manner while weights  
of the testis, seminal vesicles and prostate were found 
to increase significantly in all these three extracts17. 
The result may be due to the Rasayana property of 
Lāngali which is mentioned in texts18. 
Increase in the relative weight of spleen may be 
indicative of mild stimulation in the activity of the 
organ. Another possible reason for weight increase can 
be pathological changes like oedema formation  
etc. However, such features were not seen in 
histopathological examination of spleen hence 
pathological changes can be ruled out. Kidney weight 
was found to be significantly decreased in AS group 
which was not seen in GS TED, this indicates 
interference with kidney functioning by aśodhita sample 
which may be decreased after śodhana. However, the 
histopathological study does not reveal any changes in 
the cytoarchitecture of the kidney in both groups. 
Significant decrease in the weight of uterus in the two 
groups can be attributed to uterine contraction activity of 
the drug. However, in the higher dose group, no 
significant change in the weight was observed. 
The weight of the testis was found to be increased 
in AS TED5 group in comparison no such change 
could be observed in śodhita therapeutic dose group. 
This may be indicative of inflammatory or other 
changes since a marked decrease in spermatogenesis 
was observed in the testis of aśodhita Lāngali treated 
groups. Colchicine also resulted in a dose-related 
decrease in testis weight 2 and 8 weeks after 
injection19. Reports of a toxic effect of colchicine in 
sperm production in man and laboratory animals have 
appeared and have led to recommendations for its 
cautious use in males in the reproductive age group20.  
 
Effect on Haematological parameters (Table 4) 
WBC count was decreased in the ASTED group at  
90 days while it was normal in GSTED group at all  
the dose levels. Statistically significant decrease in 
Hb% was found 90th day at ASTED5 dose level 
while in ASTED and ASTED10 groups showed a 
statistically non-significant decrease in Hb%. It was 
found to be increased in GSTED and GSTED5 
group which was statistically non-significant. In 
GS10 group Hb% was found to be decreased. This 
means all the AS groups showed a decrease in Hb% 
significantly or insignificantly, however, it was found 
Table 3 — Effect of AS and GS on various organs of albino rats 
Relative weight  
(mg/100g) 
Control group Aśodhita (AS) Gomūtra śodhita (GS) 
TED TED5 TED10 TED TED5 TED10 
Thymus  133.70± 
6.78 
140.29± 
10.79 
158.98± 
10.17 
156.53± 
7.28*↑ 
169.85± 
14.74 
156.71± 
8.51 
156.03± 
3.43*↑ 
Heart  271.30± 
2.72 
265.82± 
10.43 
304.37± 
10.09 
294.37± 
11.51 
331.35± 
24.92 
313.21± 
12.72 
287.15± 
4.01 
Liver  2809.50± 
188.06 
2625.15± 
240.97 
2859.93± 
126.13 
3063.93± 
260.08 
3036.77± 
130.03 
3022.10± 
96.58 
2914.86± 
82.30 
Spleen  168.60± 
14.73 
136.73± 
3.08 
186.10± 
7.79 
216.38± 
11.63 
217.47± 
9.80*↑ 
173.13± 
5.70 
191.89± 
13.47 
Kidney  678.50 
 37.47 
541.43± 
34.41* 
690.55± 
18.14 
657.66± 
22.39 
763.81± 
33.41 
698.99± 
21.32 
638.58± 
20.71 
Testis  893.20± 
94.79 
964.26± 
67.92 
1180.22± 
25.24#↑ 
889.24± 
167.87 
1103.47± 
232.73 
814.73± 
223.63 
1143.98± 
283.24 
S. vesicle  402.80± 
24.47 
290.87± 
30.45 
507.86± 
34.50 
501.93± 
26.80 
528.13± 
96.64 
479.36± 
33.80 
584.37± 
53.26 
Prostate  135.30± 
1.92 
144.47± 
28.09 
149.33± 
8.70 
176.12± 
16.92 
169.56± 
28.91 
135.03± 
11.32 
162.96± 
32.59 
Uterus  239.50± 
18.7 
144.05± 
19.20* 
283.95± 
81.57 
293.89± 
31.60 
153.34± 
12.55* 
301.12± 
32.30 
219.98± 
3.76 
Data: Mean±SEM, ↑-Increase,  - Decrease, *P <0.05 when compared with control group (Unpaired ‘t’ test), #P <0.05 when compared 
with control group (ANOVA followed by Dunnett’s multiple ‘t’ test) 
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decreased only in GS10 group which was non-
significant which was highest dose level while same 
as that of control in GS and GS5 groups. The 
decreased Hb% may be due to alkaloids like 
colchicine present in the drug which is known to 
reduce Hb%21. MCH was found decreased in AS TED 
group while it was not altered at other dose levels. 
MCHC was also found decreased at all the dose levels 
except for the GS TED group which may be due to 
reduced toxicity by gomūtra. MCHC is reported to be 
decreased in iron deficiency anaemia22 hence, there 
may be a certain component in the drug which is 
responsible for decreased iron concentration in the 
blood while it was found normal in the śodhita 
samples which may be due to removal of that particular 
component through śodhana. Other parameters were 
also observed altered to a certain extent. 
Further, analysis of the haematological parameters 
shows that neutrophil percentage significantly increased 
and RBC count significantly decreased, in one or the 
other AS treated groups at some point during their 
administration these changes were not seen in GS 
sample administered groups. This indicates that śodhana 
process removes or reduces certain principles which 
have the tendency to cause changes in the haematological 
parameters mainly myelosuppression. The monocytes 
were found to be decreased in both groups. 
 
Biochemical parameters (Table 5) 
Blood sugar was decreased on 90th day at only 
AS10 dose level. It shows that the drug may be 
altering with the glucose metabolism in the body at 
the higher dose. The effect may be due to the content 
colchicine which is responsible for the decreased 
absorption of sugar from the intestine that may lead to 
decreased blood glucose level23. However, this effect 
may not be considered as toxic as the decrease was 
within normal limits. 
Triglycerides were found decreased in AS group  
at higher dose levels while it was not observed in  
GS groups which shows that GS TED is safe as 
compared to aśodhita Lāngali. Lowered triglycerides, 
cholesterol as well as HDL may also be due to the 
alkaloid colchicine which is responsible for the 
decrease in lipoproteins24. 
Alkaline phosphatase was found increased after  
90 days in all the groups. An elevation in activities of 
alkaline phosphatase can be found in diseases of the 
bone, liver and in pregnancy. In the absence of bone 
disease and pregnancy, elevated alkaline phosphatase 
levels generally reflect hepatobiliary disease. The 
greatest elevation (3 to 10 times normal) occurs in 
biliary tract obstruction. Slight to moderate increase is 
seen in parenchymal diseases such as in hepatitis  
and cirrhosis and in metastatic liver disease25. This 
increase in the alkaline phosphatase may be correlated 
to the alkaloid colchicine which is responsible for its 
increased activity26. Since histopathological slides do 
not show the cirrhotic changes in the liver this may 
indicate stimulation of the liver functions. 
Fifteen biochemical parameters were monitored 
during the study. In AS given groups (at three  
Table 4 — Effect of AS and GS on haematological parameters of albino rats 
Parameters Control group AS GS 
TED TED5 TED10 TED TED5 TED10 
TWBC 
(103/Cumm) 
9985.71  
1222.86 
8050  
1148.26 
8520.00  
946.90 
7080.00  
726.76* 
7766.67  
571.94 
8900.00  
879.27 
7650.00  
509.53 
Neutrophil (%) 23.00 0.87 22.17±4.50 27.90±3.16 29.80 ±2.24*↑ 14.50 ±1.33* 27.60±2.03 26.00±1.65 
Lymphocyte (%) 73.14±0.94 73.50±4.77 67.70±3.27 65.40 ±2.45* 81.50 ±1.57#↑ 67.90±2.22 69.33±1.84 
Eosinophils (%) 2.14±0.14 2.33±0.21 2.30±0.15 2.70±0.21 2.17±0.17 2.30±0.15 2.50±0.15 
Monocyte (%) 1.92±0.19 2.00±0.26 2.10±0.23 2.10±0.18 1.83±0.31 2.20±0.20 2.17±0.17 
Haemoglobin 
(gm%) 
15.16±0.26 14.93±0.18 14.14±0.22* 14.66±0.19 15.42±0.19 15.37±0.22 15.14±0.16 
PCV (%) 47.61 0.94 48.57 0.58 45.53 0.83 46.65 0.68 49.62 0.49 48.98 0.7 48.06 0.54 
TRBC (10e6/µL) 8.42±0.18 8.64±0.17 8.04±0.21 8.25±0.19 8.66±0.08 8.60±0.14 8.51±0.12 
Platelet (10e3/µL) 1175.57 
±46.61 
1182.67±36.83 1076.00 ±95.60 1161.10 
±44.81 
1182.33±41.71 1161.70 
±31.21 
1220.25±55.87 
MCV (fL) 56.59 ±0.42 56.23±0.46 56.82±0.85 56.62 ±0.59 57.30 ±0.66 56.98±0.48 56.48±0.31 
MCH (pg) 18.00 ±0.19 17.30±0.17* 17.63±0.28 17.87 ±0.30 17.83±0.28 17.89±0.26 17.78±0.16 
MCHC (mg/dL) 31.84 ±0.24 30.75±0.17# 31.08±0.14* 31.43 ±0.28 31.07±0.26 31.38±0.20 31.52±0.19 
Data: Mean±SEM, ↑-Increase,  - Decrease, *P <0.05 when compared with control group (Unpaired ‘t’ test), #P <0.05 when compared 
with control group (ANOVA followed by Dunnett’s multiple ‘t’ test) 
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dose levels) eleven parameters were found to be 
significantly altered. In the lower dose group, AS 
TED group – six parameters were found to be 
significantly altered. The same number of parameters 
was found to be altered in GS TED group. At AS 5 
TED and AS 10 TED, nine parameters were found to 
be altered while six parameters were found to be 
altered in GS group receiving the same doses. Four 
parameters; SGPT activity, Total protein, direct 
bilirubin, and serum glucose level were almost 
normal. This clearly shows that śodhana process is 
effective in reducing the toxic potential of the 
aśodhita Lāngali. 
 
Histopathological study 
Histopathological study shows that among 16 
organs studied, significant pathological changes were 
observed in kidney, liver and testis (Plate 1-5). 
Aśodhita Lāngali (AS) group only one kidney section 
was observed with epithelial cell disruption and 
haemorrhage patch. However, sections of testis 
exhibited a marked decrease in spermatogenesis and 
necrotic changes in the spermatids. Increase in the 
proportion of interstitial cells was seen in most of the 
testis section in this group. In Gomūtra shodhtia 
Lāngali (GS) group central vein congestion and 
increase Kupffer cell was observed in one section of 
the liver only. Two sections of kidneys exhibited 
normal profile whereas hemorrhagic streaks of 
moderate-intensity were seen in the other two 
sections. However, such haemorrhagic changes were 
observed in the control group also and hence, may not 
be considered pathologic. Degenerative changes  
were not observed in the testis sections from GS 
administered groups. A decrease in spermatogenesis 
in the AS treated group and good spermatogenesis in 
GS treated group shows that śodhana process with 
gomūtra may have removed the toxic principle11 
which may be responsible for the degenerative 
changes observed in the testis.  
Table 5 — Effect of Aśodhita and Gomūtra śodhita Lāngali on serum biochemical parameters of albino rats 
Parameters Control group AS GS 
TED TED5 TED10 TED TED5 TED10 
FBS (mg/dL) 96.28±3.65 101.00±1.21 81.80±5.07 79.00±4.49# 106.50±4.75 86.20±5 86.00±3.06 
Cholesterol 
(mg/dL) 
53.86±3.39 101.00±1.21 46.50±3.81 44.30±2.97 106.50±4.75 49.80±2.89 51.67±3.27 
Trigliceride 
(mg/dL) 
129.71 ±10.69 117.67±20.54 98.30±6.68* 100.70±5.74* 109.50±13.51 116.50 ±11.81 101.33±9.42 
HDL (mg/dL) 34.71±2.22 30.17±3.53 29.10±1.91 26.90±2.54* 28.33±1.82 31.50±1.29 33.58±2.63 
Urea (mg/dL) 63.86±1.89 61.17±3.09 53.40±1.66# 60.80±2.89 54.00±5.68 58.80±2.62 58.67±1.32* 
Creatinine (mg/dL) 0.64±0.04 0.63±0.02 0.67±0.02 0.64±0.03 0.60±0.03 0.67±0.02 0.62±0.03 
SGPT (IU/L) 37.71±3.24 54.17±3.12* 43.90±3.33 45.20±2.79 65.50±11.69# 44.10±2.86 37.50±2.13 
SGOT (IU/L) 156.86 ±12.25 140.17±5.18 162.70 ±11.26 155.40±9.68 153.17±13.29 159.20 ±13.62 138.92±8.46 
Total protein 
(g/dL) 
7.59±0.09 7.88±0.07* 7.22±0.16 7.48±0.16 8.05±0.03* 7.69±0.11 7.87±0.11 
Albumin (g/dL) 4.29±0.09 3.95±0.06* 5.31±0.54 3.69±0.11* 3.85±0.07* 5.94±0.65 4.01±0.07* 
Globulin (gm/dL) 3.30±0.09 3.93±0.11* 3.76±0.10* 3.79±0.23 4.20±0.09# 3.70±0.13* 3.86±0.11# 
ALP (IU/L) 104.57 ±16.17 300.17±27.18# 192.10 ±18.43# 207.90 ±20.14# 279.17±27.68# 198.70 ±21.87# 154.75 ±15.44* 
T. Billirubin 
(mg/dL) 
0.43 0.03 0.57 0.07 0.39 0.05 0.48 0.03 0.50±0.06 0.34 0.04 0.41 0.03 
D. billirubin 
(mg/dL) 
0.10±0.00 0.15±0.02* 0.14±0.02 0.12±0.01 0.15±0.02* 0.10±0.00 0.11±0.01 
Uric acid (mg/dL) 0.84±0.08 0.80±0.13 0.75±0.07 0.65±0.05* 0.90±0.12 0.84±0.08 0.87±0.08 
Data: Mean±SEM, ↑-Increase,  - Decrease, *P <0.05 when compared with control group (Unpaired ‘t’ test), # P <0.05 when compared 
with control group (ANOVA followed by Dunnett’s multiple ‘t’ test) 
 
 
 
Plate 1 — Kidney (AS 10 group) showing haemorrhagic streaks 
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Conclusion 
No mortality and significant behavioural changes 
were observed during the chronic toxicity study. No 
significant behavioural changes were observed. The 
results indicate that śodhana process removes  
or reduces certain principles which have the tendency 
to cause changes in some haematological and 
biochemical parameters. Raw Lāngali, at ten times 
dose level, showed significant alterations in some 
haematological and biochemical parameters. Raw 
Lāngali, at ten times dose level also showed decreased 
spermatogenesis whereas GS Lāngali showed moderate 
to good spermatogenesis. So it can be concluded that 
both raw and śodhita Lāngali found relatively safe up 
to five times therapeutic dose level. 
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